Literature DB >> 19178392

Ophthalmic lymphoma: epidemiology and pathogenesis.

Lene Dissing Sjö1.   

Abstract

With a lifetime risk of 1% and 700 new cases per year, Non-Hodgkin lymphoma (NHL) is the seventh most frequent type of cancer in Denmark. The incidence of NHL has increased considerably in Western countries over the last decades; consequently, NHL is an increasing clinical problem. Ophthalmic lymphoma, (lymphoma localized in the ocular region, i.e. eyelid, conjunctiva, lacrimal sac, lacrimal gland, orbit, or intraocularly) is relatively uncommon, accounting for 5%-10% of all extranodal lymphomas. It is, however, the most common orbital malignancy. The purpose of this thesis was to review specimens from all Danish patients with a diagnosis of ophthalmic lymphoma during the period 1980-2005, in order to determine the distribution of lymphoma subtypes, and the incidence- and time trends in incidence for ophthalmic lymphoma. Furthermore, an extended analysis of the most frequent subtype, extranodal marginal zone lymphoma (MALT lymphoma), was done to analyse clinical factors and cytogenetic changes with influence on prognosis. A total of 228 Danish patients with a biopsy-reviewed verified diagnosis of ocular adnexal-, orbital-, or intraocular lymphoma were identified. We found that more than 50% of orbital- and ocular adnexal lymphomas were of the MALT lymphoma subtype, whereas diffuse large B-cell lymphoma (DLBCL) predominated intraocularly (Sjo et al. 2008a). Furthermore, lymphoma arising in the lacrimal sac was surprisingly predominantly DLBCL (Sjo et al. 2006). Incidence rates were highly dependent on patient age. There was an increase in incidence rates for the whole population from 1980 to 2005, corresponding to an annual average increase of 3.4% (Sjo et al. 2008a). MALT lymphoma arising in the ocular region was found in 116 patients (Sjo et al. 2008b). One third of patients had a relapse or progression of disease after initial therapy and relapses were frequently found at extra-ocular sites. Overall survival, however, was not significantly poorer for patients with relapse. Furthermore, we found that the frequency of translocations involving the MALT1- and IGH-gene loci is low in ocular region MALT lymphoma (2 of 42, 5%), but may predict increased risk of relapse (Sjo et al. 2008b). In conclusion the incidence of ophthalmic lymphoma is increasing at a high rate in Denmark. Ophthalmic lymphoma consists primarily of MALT lymphoma. The molecular pathogenesis of MALT lymphoma arising in the ocular region rarely involves translocations in the MALT1- and IGH-gene loci.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19178392     DOI: 10.1111/j.1755-3768.2008.01478.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  22 in total

1.  Low-grade systemic lymphoma with aggressive transformation in the lacrimal sac.

Authors:  N M Peter; R Khooshabeh
Journal:  Eye (Lond)       Date:  2012-03-02       Impact factor: 3.775

2.  Histopathological Features and Ann Arbor Stage in Periocular Lymphoma.

Authors:  Marco Zschoche; Annette Zimpfer; Björn O Scheef; Anselm M Jünemann; Rudolf F Guthoff; Christian Junghanss; Guido Hildebrandt; Steffen Emmert; Andreas Erbersdobler; Günther Kundt; Vinodh Kakkassery
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

3.  Conjunctival lymphoma.

Authors:  Jenny Jing Li; Weina Chen; Navid Sadeghi
Journal:  BMJ Case Rep       Date:  2019-07-10

Review 4.  Updates in Ocular Surface Tumor Diagnostics.

Authors:  Afshan A Nanji; Carolina Mercado; Anat Galor; Sander Dubovy; Carol L Karp
Journal:  Int Ophthalmol Clin       Date:  2017

5.  Orbital lymphoma masquerading as panuveitis.

Authors:  Puneet Panda; Farzin Forooghian; Todd Goodglick; Chi-Chao Chan; Robert Nussenblatt; H Nida Sen
Journal:  Ocul Immunol Inflamm       Date:  2010-06       Impact factor: 3.070

6.  MR-based radiomics signature in differentiating ocular adnexal lymphoma from idiopathic orbital inflammation.

Authors:  Jian Guo; Zhenyu Liu; Chen Shen; Zheng Li; Fei Yan; Jie Tian; Junfang Xian
Journal:  Eur Radiol       Date:  2018-04-09       Impact factor: 5.315

7.  Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.

Authors:  P J Simpson-Haidaris; S J Pollock; S Ramon; N Guo; C F Woeller; S E Feldon; R P Phipps
Journal:  PPAR Res       Date:  2010-02-28       Impact factor: 4.964

8.  Nasal dissemination of a single-clone IgH-rearranged conjunctival MALT lymphoma through the nasolacrimal duct: A case report.

Authors:  Chung-Yu Hsieh; Yi-Ping Liao; Chia-Che Wu; Sheng-Po Yuan; Jennifer Hui-Chun Ho; Rachel Roan; Phui-Ly Liew; Ming-Tang Lai; Feipeng Lee
Journal:  Oncol Lett       Date:  2016-06-10       Impact factor: 2.967

9.  Primary extranodal marginal zone lymphoma of the uvea associated with massive diffuse epibulbar extension and focal infiltration of the optic nerve and meninges, clinically presented as uveitis masquerade syndrome: a case report.

Authors:  D M Rasić; Z Stanković; T Terzić; D Kovacević; Z Koturović; V Marković
Journal:  Med Oncol       Date:  2009-10-09       Impact factor: 3.064

10.  Distinct microRNA-155 expression in the vitreous of patients with primary vitreoretinal lymphoma and uveitis.

Authors:  Jingsheng Tuo; Defen Shen; Howard Hua Yang; Chi-Chao Chan
Journal:  Am J Ophthalmol       Date:  2013-12-15       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.